Crist, Richard C.
Phillips, Karran A.
Furnari, Melody A.
Moran, Landhing M.
Doyle, Glenn A.
McNicholas, Laura F.
Cornish, James W.
Kampman, Kyle M.
Preston, Kenzie L.
Berrettini, Wade H.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (K01 DA036751, R01 DA044015, R01 DA044015, U10 DA13043, R21 DA036808, R01 DA044015)
Article History
Received: 27 March 2018
Revised: 24 August 2018
Accepted: 27 September 2018
First Online: 27 October 2018
Compliance with ethical standards
:
: KMK has received consulting fees from Alkermes and Opiant Pharmaceuticals. He has also received grant funding from Alkermes, Opiant Pharmaceuticals, and Indivior. WHB has received consulting fees from Mundipharma and Geisinger Health Systems and grant support from Saniona. The remaining authors declare no conflict of interests.